Acutis Biosciences

Executive Summary

Acutis Biosciences (d/b/a Acutis Diagnostics) is a privately held clinical laboratory based in Port Jefferson, New York, founded in 2015. The company specializes in advanced PCR-based diagnostic testing for infectious diseases, including urinary tract infections, respiratory and gastrointestinal pathogens, and sexually transmitted infections. It also offers comprehensive clinical toxicology testing for medication monitoring and substance use. Additionally, Acutis provides contract research solutions to biopharma and IVD partners in oncology and infectious disease, leveraging its CLIA-certified lab infrastructure. With a focus on rapid, high-sensitivity molecular diagnostics, the company serves healthcare providers and clinical research organizations in the New York metropolitan area and beyond.

Upcoming Catalysts (preview)

• Q3 2026Expansion of UTI Diagnostic Panel to Include Antimicrobial Resistance Markers70% success
• Q2 2026Partnership with a Major Hospital System for Clinical Trial Testing Services50% success
• Q1 2027FDA 510(k) Clearance for a Novel STI Multiplex Test40% success